Advanced Medicine

In our second C+G Champions installment, we ask industry leaders in the cell and gene field to answer key questions about the industry.

What will drug development look like aboard a new commercial space station?

Is commercializing gene therapy manufacturing an unsolvable problem? We ask an expert on the frontlines.

How bioelectronic assays helped demonstrate the value of 3D iPSC cultures in modeling human brain development.

What are the key decisions that need to be made for cell therapy supply chains?

The Medicine Maker’s round up of the top news stories in the pharma industry in March.

How pharmaceutical therapeutics are expanding into a whole new galaxy of options.

We want to hear your thoughts on what mRNA could do for cell and gene therapy

Sitting Down With Dolores Schendel, Chief Executive Officer and Chief Scientific Officer at Medigene.

Nominations and voting for the Power List, Company of the Year Awards, and Innovation Awards ends on Thursday 17 March